Electra Therapeutics, Inc.

Electra Therapeutics, Inc.

NNASDAQ:ETRA
8.31
USD
-0.53
(-6.00%)
Mar 03Next Earn

Important Dates

Electra Therapeutics, Inc.'s next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of June 30, 2026, Electra Therapeutics, Inc. has 62.77M shares outstanding.

Shares Outstanding62.77M

Financial Position

As of June 30, 2026, Electra Therapeutics, Inc. maintains a current ratio of 7.37, meaning it holds 7.4x the short-term assets needed to cover near-term liabilities.

Current Ratio7.37
Quick Ratio7.19
Debt / Equity-7.41

Balance Sheet

USD

As of June 30, 2026, Electra Therapeutics, Inc. holds 97.73M in cash and equivalents against 1.98M in total debt, resulting in a net debt position of -66.51M. Total book value stands at -219.45M, with working capital of 86.74M providing operational flexibility.

Cash & Cash Equivalents97.73M
Total Debt1.98M
Net Debt-66.51M
Equity (Book Value)-219.45M
Book Value Per Share-3.50
Working Capital86.74M